159 related articles for article (PubMed ID: 19455260)
1. Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cells.
Racchi G; Klingel K; Kandolf R; Grassi G
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):63-70. PubMed ID: 19455260
[TBL] [Abstract][Full Text] [Related]
2. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice.
Merl S; Michaelis C; Jaschke B; Vorpahl M; Seidl S; Wessely R
Circulation; 2005 Apr; 111(13):1583-92. PubMed ID: 15795330
[TBL] [Abstract][Full Text] [Related]
3. A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge.
Ahn J; Jun ES; Lee HS; Yoon SY; Kim D; Joo CH; Kim YK; Lee H
J Virol; 2005 Jul; 79(13):8620-4. PubMed ID: 15956603
[TBL] [Abstract][Full Text] [Related]
4. [Short interfering RNA-mediated inhibition of coxsakievirus B3 infection in vitro].
Han JS; Xiao ZH; Yao HL; Ren HY; Liu ZW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):150-2. PubMed ID: 17653320
[TBL] [Abstract][Full Text] [Related]
5. [Intracellular clearance of Coxsakievirus B3 infection by short interfering RNA and its mechanism study].
Xiao ZH; Han JS; Yao HL; Liu ZW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):260-2. PubMed ID: 19105337
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.
Yuan J; Cheung PK; Zhang HM; Chau D; Yang D
J Virol; 2005 Feb; 79(4):2151-9. PubMed ID: 15681418
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of CVB3-VP1 siRNA on CVB3 replication].
Chen JB; Xu CF; Yu Y; Li L; Li SJ; Chen RZ; Yang YZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):306-9. PubMed ID: 16643786
[TBL] [Abstract][Full Text] [Related]
8. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
9. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
10. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
Pinkert S; Westermann D; Wang X; Klingel K; Dörner A; Savvatis K; Grössl T; Krohn S; Tschöpe C; Zeichhardt H; Kotsch K; Weitmann K; Hoffmann W; Schultheiss HP; Spiller OB; Poller W; Fechner H
Circulation; 2009 Dec; 120(23):2358-66. PubMed ID: 19933937
[TBL] [Abstract][Full Text] [Related]
12. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
Kim JY; Chung SK; Hwang HY; Kim H; Kim JH; Nam JH; Park SI
Virus Res; 2007 Apr; 125(1):9-13. PubMed ID: 17222937
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA against the 2C genomic region of coxsackievirus B3 exerts potential antiviral effects in permissive HeLa cells.
Luan Y; Dai HL; Yang D; Zhu L; Gao TL; Shao HJ; Peng X; Jin ZF
Virus Res; 2012 Jan; 163(1):183-9. PubMed ID: 21945637
[TBL] [Abstract][Full Text] [Related]
15. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection.
Hanson PJ; Hossain AR; Qiu Y; Zhang HM; Zhao G; Li C; Lin V; Sulaimon S; Vlok M; Fung G; Chen VH; Jan E; McManus BM; Granville DJ; Yang D
Front Cell Infect Microbiol; 2019; 9():265. PubMed ID: 31396490
[TBL] [Abstract][Full Text] [Related]
16. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor.
Werk D; Schubert S; Lindig V; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Biol Chem; 2005 Sep; 386(9):857-63. PubMed ID: 16164410
[TBL] [Abstract][Full Text] [Related]
17. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
Lee C; Maull E; Chapman N; Tracy S; Gauntt C
J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
[TBL] [Abstract][Full Text] [Related]
18. A novel program to design siRNAs simultaneously effective to highly variable virus genomes.
Lee HS; Ahn J; Jun EJ; Yang S; Joo CH; Kim YK; Lee H
Biochem Biophys Res Commun; 2009 Jul; 384(4):431-5. PubMed ID: 19422797
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
20. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
